from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3334/-

LFCtreatmentdescriptionclass of inhibitor

1.818

Amikacinug/mL Amikacintranslation

1.820

Cap5-10ug/mL Capreomycintranslation

2.367

Rox10-50 ug/mL Roxithromycintranslation

0.552

SM2-5 ug/mL Streptomycintranslation

1.822

Tet5-10 ug/mL Tetracyclinetranslation

-0.581

Rif0.2-5ug/mL Rifampicintranscription

-0.133

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.242

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.803

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.040

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.396

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.692

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

2.694

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.975

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.258

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.472

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.265

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.056

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.531

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

1.301

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.876

KCN5-20 ug/mL Potassium cyaniderespiration

-0.523

NaN30.2-2 mM Sodium aziderespiration

-0.277

Nigericin50 uM Nigericinrespiration

0.713

TRC10-150 ug/mL Triclosanrespiration

1.891

TRZ10-25 ug/mL Thioridazinerespiration

2.272

Valinomycin0.5-10 uM Valinomycinrespiration

-1.349

ZnSO42 mM ZnSO4respiration

0.638

menadione6-10 ug/mL Menadionerespiration

-0.333

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.419

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.378

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.478

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.536

NRP_1Non-replicating persistence stage 1dosRassociated

-0.656

Amp0.2mg/mL AmpicillincellWall

-0.442

Cephalexin20-100 ug/mL CephalexincellWall

-0.453

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.493

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.580

EMB10-20 ug/mL EthambutolcellWall

-0.693

Eta12-40 ug/mL EthionamidecellWall

-0.885

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.557

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.037

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.029

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.353

BZA0.12 mg/mL BenzamidearomaticAmides

0.033

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

1.203

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.404

H2O24 mM hydrogen peroxideDNAdamaging

-0.264

Levo10 ug/mL LevofloxacinDNAdamaging

-0.683

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.400

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.380

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.732

UVUV-irradiationDNAdamaging

1.884

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.694

Antimycin12.5-50 ug/mL Antimycin A?

-0.254

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.370

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.415

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.635

PA8240.2-2 ug/mL PA-824?

0.001

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.992

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.077

Verapamil50 uM Verapamil?

-0.011

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.313

methoxatin10-20 ug/mL Methoxatin?